{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:07:18Z","timestamp":1780304838309,"version":"3.54.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bbrc.2025.152645","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T03:46:45Z","timestamp":1757994405000},"page":"152645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Salvigenin inhibits gastric cancer progression by suppressing the EGFR\/PI3K\/AKT pathway"],"prefix":"10.1016","volume":"784","author":[{"given":"Kuan","family":"Qiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bbrc.2025.152645_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","article-title":"Gastric cancer, version 2.2022, NCCN Clinical Practice Guidelines in oncology","volume":"20","author":"Ajani","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw. : J. Natl. Compr. Cancer Netw."},{"issue":"3","key":"10.1016\/j.bbrc.2025.152645_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16030560","article-title":"Therapeutic immunomodulation in gastric cancer","volume":"16","author":"Akkanapally","year":"2024","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.bbrc.2025.152645_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11040625","article-title":"Hyperthermia treatment as a promising anti-cancer strategy: therapeutic targets, perspective mechanisms and synergistic combinations in experimental approaches","volume":"11","author":"Yi","year":"2022","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.bbrc.2025.152645_bib4","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cancers6031769","article-title":"Drug resistance in cancer: an overview","volume":"6","author":"Housman","year":"2014","journal-title":"Cancers"},{"issue":"22","key":"10.1016\/j.bbrc.2025.152645_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25225243","article-title":"Important flavonoids and their role as a therapeutic agent","volume":"25","author":"Ullah","year":"2020","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bbrc.2025.152645_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/nu12030761","article-title":"Flavonoids and Other Polyphenols Act as epigenetic modifiers in breast cancer","volume":"12","author":"Selvakumar","year":"2020","journal-title":"Nutrients"},{"issue":"15","key":"10.1016\/j.bbrc.2025.152645_bib7","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2174\/1389557519666190617150051","article-title":"The roles of Flavonols\/Flavonoids in neurodegeneration and neuroinflammation","volume":"20","author":"Calis","year":"2020","journal-title":"Mini Rev. Med. Chem."},{"issue":"8","key":"10.1016\/j.bbrc.2025.152645_bib8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2174\/1389557515666150709110222","article-title":"Bergamot (Citrus bergamia risso) flavonoids and their potential benefits in human hyperlipidemia and atherosclerosis: an overview","volume":"16","author":"Cappello","year":"2016","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.bbrc.2025.152645_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.pestbp.2024.105966","article-title":"Therapeutic potential of salvigenin to combat atrazine induced liver toxicity in rats via regulating Nrf-2\/Keap-1 and NF-\u03baB pathway","volume":"202","author":"Edwards","year":"2024","journal-title":"Pestic. Biochem. Physiol."},{"issue":"1\u20132","key":"10.1016\/j.bbrc.2025.152645_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11010-012-1416-6","article-title":"Increase of autophagy and attenuation of apoptosis by Salvigenin promote survival of SH-SY5Y cells following treatment with H2O2","volume":"371","author":"Rafatian","year":"2012","journal-title":"Mol. Cell. Biochem."},{"issue":"7","key":"10.1016\/j.bbrc.2025.152645_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10071042","article-title":"Salvigenin, a trimethoxylated flavone from Achillea Wilhelmsii C. Koch, exerts combined lipid-lowering and mitochondrial stimulatory effects","volume":"10","author":"Serino","year":"2021","journal-title":"Antioxidants"},{"issue":"2","key":"10.1016\/j.bbrc.2025.152645_bib12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1080\/01635581.2022.2135744","article-title":"Role of plant-derived flavonoids in cancer treatment","volume":"75","author":"Tiwari","year":"2023","journal-title":"Nutr. Cancer"},{"issue":"23","key":"10.1016\/j.bbrc.2025.152645_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25235628","article-title":"Flavonoids regulate inflammation and oxidative stress in cancer","volume":"25","author":"Li","year":"2020","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.bbrc.2025.152645_bib14","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1007\/s12010-023-04511-z","article-title":"Salvigenin suppresses hepatocellular carcinoma glycolysis and chemoresistance through inactivating the PI3K\/AKT\/GSK-3\u03b2 Pathway","volume":"195","author":"Shao","year":"2023","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152645_bib15","first-page":"131","article-title":"Eupatorin and salvigenin potentiate doxorubicin-induced apoptosis and cell cycle arrest in HT-29 and SW948 human Colon cancer cells","volume":"19","author":"Namazi Sarvestani","year":"2018","journal-title":"Asian Pac. J. Cancer Prev. APJCP : Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.bbrc.2025.152645_bib16","article-title":"Mechanism of lethal skin toxicities induced by epidermal growth factor receptor inhibitors and related treatment strategies","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"issue":"26","key":"10.1016\/j.bbrc.2025.152645_bib17","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.3748\/wjg.v24.i26.2818","article-title":"Biomarkers of gastric cancer: current topics and future perspective","volume":"24","author":"Matsuoka","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"1\u20132","key":"10.1016\/j.bbrc.2025.152645_bib18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cellimm.2013.10.005","article-title":"Antitumor and immunomodulatory effects of salvigenin on tumor bearing mice","volume":"286","author":"Noori","year":"2013","journal-title":"Cell. Immunol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152645_bib19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13046-023-02618-z","article-title":"Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling","volume":"42","author":"Huang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res. : CR"},{"issue":"3","key":"10.1016\/j.bbrc.2025.152645_bib20","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008912","article-title":"Receptor tyrosine kinases: legacy of the first two decades","volume":"6","author":"Schlessinger","year":"2014","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"8","key":"10.1016\/j.bbrc.2025.152645_bib21","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1172\/JCI32278","article-title":"ErbB receptors: from oncogenes to targeted cancer therapies","volume":"117","author":"Zhang","year":"2007","journal-title":"J. Clin. Investig."},{"issue":"10","key":"10.1016\/j.bbrc.2025.152645_bib22","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/modpathol.3800417","article-title":"Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization study","volume":"18","author":"Shia","year":"2005","journal-title":"Mod. Pathol. : an official journal of the United States and Canadian Academy of Pathology, Inc"},{"key":"10.1016\/j.bbrc.2025.152645_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejmech.2018.05.006","article-title":"Design, synthesis, antiproliferative activity and docking studies of quinazoline derivatives bearing 2,3-dihydro-indole or 1,2,3,4-tetrahydroquinoline as potential EGFR inhibitors","volume":"154","author":"OuYang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bbrc.2025.152645_bib24","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1158\/1078-0432.CCR-06-2167","article-title":"Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder","volume":"13","author":"Wang","year":"2007","journal-title":"Clin. Cancer Res. : an official journal of the American Association for Cancer Research"},{"issue":"2","key":"10.1016\/j.bbrc.2025.152645_bib25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0092-8674(00)00114-8","article-title":"Cell signaling by receptor tyrosine kinases","volume":"103","author":"Schlessinger","year":"2000","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.bbrc.2025.152645_bib26","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.7150\/ijbs.83682","article-title":"Polyphyllin VII induces CTC anoikis to inhibit lung cancer metastasis through EGFR pathway regulation","volume":"19","author":"Que","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbrc.2025.152645_bib27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbrc.2023.04.080","article-title":"Neuroglobin inhibits pancreatic cancer proliferation and metastasis by targeting the GNAI1\/EGFR\/AKT\/ERK signaling axis","volume":"664","author":"Wu","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bbrc.2025.152645_bib28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40001-024-01637-6","article-title":"Gentiopicroside inhibits the progression of gastric cancer through modulating EGFR\/PI3K\/AKT signaling pathway","volume":"29","author":"Chen","year":"2024","journal-title":"Eur. J. Med. Res."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25013610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25013610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:33:23Z","timestamp":1780302803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25013610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":28,"alternative-id":["S0006291X25013610"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152645","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salvigenin inhibits gastric cancer progression by suppressing the EGFR\/PI3K\/AKT pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152645","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152645"}}